Development

Articles

Novasep is building a new synthesis laboratory and adding capacity for kilogram-scale batches of synthetic molecules that are needed for biological testing and preclinical trials, at its Pennsylvania, US facility.

Novasep Adds Small-Scale Manufacturing Capability to US Facility

Planned expansion at Onyx Scientific add laboratories, GMP suites, and storage space.

Onyx Scientific Announces Facility Expansion

Andrew Badrot, founder and CEO of Centroflora CMS, discussed the acquisition and technical transfer of Boehringer Ingelheim’s (BI) non-captive phytochemical API portfolio with Pharmaceutical Technology.

A conversation with Centroflora CMS

FDA issued a warning letter to Zhejiang Hisun Pharmaceutical Co., Ltd., as a result of inspections that took place on March 2–7, 2015 at the Taizhou City, Zhejiang Province, API manufacturing facility.

Chinese API Manufacturer Zhejiang Hisun Receives Warning Letter

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Nanoscale catalysts and engineered nanoparticles may have a big impact on small-molecule pharmaceuticals.

Nanotechnology  Shows Promise for API Synthesis and Delivery

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

FDA approved 45 novel new drugs in 2015, the highest number of approvals since 1996 and second-highest ever.

Expedited Approvals and Orphan Drugs Dominated 2015 Novel New Drugs

BASF and Sumitomo Chemical explore in vitro system for chemical safety evaluation.

Collaboration Seeks to Reduce Animal Testing

Capsugel adds clinical trial and commercial manufacturing, as well as particle engineering services with two acquisitions.

Capsugel to Acquire Xcelience and Powdersize

A strong API market is expected in 2016 despite fewer new drug approvals.

Outlook Bright for Branded and Generic Active Ingredients

The ReactoMate Datum controlled lab reactor system accommodates a range of vessel sizes.